New Vaccine Introductions in WHO African Region between 2000 and 2022
Open Access
Abstract
Significant progress has been made in vaccine development worldwide. This study examined the WHO African Region’s vaccine introduction trends from 2000 to 2022, excluding COVID-19 vaccines. We extracted data on vaccine introductions from the WHO/UNICEF joint reporting form for 17 vaccines. We examined the frequency and percentages of vaccine introductions from 2000 to 2022, as well as between two specific time periods (2000–2010 and 2011–2022). We analysed Gavi eligible and ineligible countries separately and used a Chi-squared test to determine if vaccine introductions differed significantly. Three vaccines have been introduced in all 47 countries within the region: hepatitis B (HepB), Haemophilus influenzae type b (Hib), and inactivated polio vaccine (IPV). Between 2011 and 2022, HepB, Hib, IPV, the second dose of measles-containing vaccine (MCV2), and pneumococcal conjugate vaccine (PCV) were the five most frequently introduced vaccines. Hepatitis A vaccine has only been introduced in Mauritius, while Japanese encephalitis vaccine has not been introduced in any African country. Between 2000–2010 and 2011–2022, a statistically significant rise in the number of vaccine introductions was noted (p < 0.001) with a significant positive association between Gavi eligibility and vaccine introductions (p < 0.001). Significant progress has been made in the introduction of new vaccines between 2000 and 2022 in the WHO African Region, with notable introductions between 2011 and 2022. Commitments from countries, and establishing the infrastructure required for effective implementation, remain crucial.Keywords
This publication has 29 references indexed in Scilit:
- Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control AnalysesClinical Infectious Diseases, 2016
- Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in GhanaClinical Infectious Diseases, 2016
- Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysisThe Lancet Global Health, 2016
- The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experienceHuman Vaccines & Immunotherapeutics, 2015
- Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control studyThe Lancet Infectious Diseases, 2014
- Haemophilus influenzae Type b Disease among Children in Rural Mozambique: Impact of Vaccine IntroductionThe Journal of Pediatrics, 2013
- Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic reviewVaccine, 2012
- Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type b vaccine experiencePhilosophical Transactions of the Royal Society B: Biological Sciences, 2011
- Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa2006
- Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine Introduction Into Routine Childhood Immunization in KenyaJAMA, 2006